Cart
sales@molnova.com
SEL120-34A
CAS No. 1609522-33-9
SEL120-34A ( SEL 120-34A )
Catalog No. M12318 CAS No. 1609522-33-9
SEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 161 | Get Quote |
|
| 5MG | 251 | Get Quote |
|
| 10MG | 376 | Get Quote |
|
| 25MG | 626 | Get Quote |
|
| 50MG | 889 | Get Quote |
|
| 100MG | 1197 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSEL120-34A
-
NoteResearch use only, not for human use.
-
Brief DescriptionSEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively.
-
DescriptionSEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively; shows no significant inhibition on other members of the CDK family (200-fold over CDK9); inhibits phosphorylation of STAT1 S727 and STAT5 S726 in cancer cells, inhibits IFN- responsive genes expression in vitro; exhibits complete inhibitions of STAT1 S727 and STAT5 S726 in Colo-205 CRC xenograft tissues in mice (60mg/kg).
-
SynonymsSEL 120-34A
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1609522-33-9
-
Formula Weight414.15
-
Molecular FormulaC15H18Br2N4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C2C3=C(CCCN3C(=N2)N4CCNCC4)C(=C1Br)Br
-
Chemical Name7,8-Dibromo-9-methyl-2-piperazin-1-yl-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rzymski T, et al. Oncotarget. 2017 May 16;8(20):33779-33795.
molnova catalog
related products
-
KB-0742 dihydrochlor...
KB-0742 dihydrochloride is a potent, selective and orally inhibitor of ?CDK9.
-
CDK2 inhibitor 73
A potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
-
THZ2
THZ2, an analogue of THZ1 with improved pharmacokinetic features, is a potent, selective CDK7 inhibitor with IC50 of 13.9 nM, displays a 5-fold improved half-life in vivo compared with THZ1.
